Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 163-168, March 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burdette, W. J.
Right arrow Articles by Haddox, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burdette, W. J.
Right arrow Articles by Haddox, C. H., Jr.

Mutation Rate Following Treatment of Neurospora with 20-Methylcholanthrene and 1,2,5,6-Dibenzanthracene in Tween-80*

Walter J. Burdette and C. H. Haddox, Jr.

( Department of Surgery, Louisiana State University School of Medicine, New Orleans, La.)

1. Reverse mutation rate at a single gene locus in Neurospora crassa after treatment with 20-methylcholanthrene or 1,2,5,6-dibenzanthracene could be explained more satisfactorily on the basis of selection than a valid increase in mutation frequency.
2. With the use of a technic of direct ascospore isolation, no increase in occurrence of biochemical mutants was found after treatment of Neurospora with 20-methylcholanthrene or 1,2,5,6-dibenzanthracene.
3. Tween-80 is used as a carbon source by Neurospora, and results are profoundly altered when it is used as solvent for carcinogens.

* Aided by a grant from the National Cancer Institute, Department of Health, Education, and Welfare.

Received 8/12/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.